Source: Simply Better Brands Corp.
  • Simply Better Brands Corp. (SBBC) has completed the first tranche of its previously announced non-brokered private placement
  • The company issued a total of 4,718,203 common ‎shares for gross proceeds of $1,391,869.69
  • The proceeds from the first tranche will be used to reduce debt and for general working capital purposes
  • Simply Better Brands Corp focuses on promoting healthy and active lifestyles
  • Simply Better Brands Corp. (SBBC) opened the day trading at $0.365

Simply Better Brands Corp. (SBBC) has completed the first tranche of its non-brokered private placement offering of common ‎shares.

The company issued a total of 4,718,203 common ‎shares for gross proceeds of $1,391,869.69.

The first tranche is part of a ‎larger private placement offering of up to 11,016,949 common ‎shares for aggregate gross proceeds of up to $3,250,000.‎

The company expects the offering to be fully subscribed.

All shares issued are ‎subject to a statutory four-month hold period that expires on November 26, 2022.‎

The proceeds from the first tranche will be used to reduce debt and for general working capital purposes.

Simply Better Brands Corp. leads an international omni-channel platform with diversified assets in the emerging plant-based and holistic wellness consumer product categories.

Simply Better Brands Corp. (SBBC) opened the day trading at $0.365 per share.


More From The Market Online

“Paw Patrol” owners see a 52-week share price high

Spin Master (TSX:TOY) reported 8.9 per cent revenue growth to US$436.4 million and returned to profitability.

Uber Eats expands grocery delivery network with new U.S. regional retail partners

Uber (NYSE:UBER) Eats added Busch’s Fresh Food Market, Hays, and Lowe’s Market to its grocery delivery marketplace across the U.S.

Cybersecurity stocks worth watching as digital risks continue to evolve

Cybersecurity threats continue to evolve, while recent disruptions highlighted the importance of resilient digital infrastructure.

A small-cap contender looking to challenge the weight-loss drug giants

Structure Therapeutics (NASDAQ:GPCR) is developing an oral weight-loss pill that could offer an alternative to popular injectable treatments.